Destruction of Lysozyme Amyloid Fibrils Induced by Magnetoferritin and Reconstructed Ferritin.

destruction ferritin iron release lysozyme amyloid fibrils magnetoferritin reconstructed ferritin

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
11 Nov 2022
Historique:
received: 11 10 2022
revised: 02 11 2022
accepted: 10 11 2022
entrez: 26 11 2022
pubmed: 27 11 2022
medline: 30 11 2022
Statut: epublish

Résumé

Neurodegenerative disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), or systemic amyloidosis, are characterized by the specific protein transformation from the native state to stable insoluble deposits, e.g., amyloid plaques. The design of potential therapeutic agents and drugs focuses on the destabilization of the bonds in their beta-rich structures. Surprisingly, ferritin derivatives have recently been proposed to destabilize fibril structures. Using atomic force microscopy (AFM) and fluorescence spectrophotometry, we confirmed the destructive effect of reconstructed ferritin (RF) and magnetoferritin (MF) on lysosome amyloid fibrils (LAF). The presence of iron was shown to be the main factor responsible for the destruction of LAF. Moreover, we found that the interaction of RF and MF with LAF caused a significant increase in the release of potentially harmful ferrous ions. Zeta potential and UV spectroscopic measurements of LAF and ferritin derivative mixtures revealed a considerable difference in RF compared to MF. Our results contribute to a better understanding of the mechanism of fibril destabilization by ferritin-like proteins. From this point of view, ferritin derivatives seem to have a dual effect: therapeutic (fibril destruction) and adverse (oxidative stress initiated by increased Fe

Identifiants

pubmed: 36430405
pii: ijms232213926
doi: 10.3390/ijms232213926
pmc: PMC9696235
pii:
doi:

Substances chimiques

Amyloid 0
Muramidase EC 3.2.1.17
magnetoferritin 0
Ferritins 9007-73-2
Iron E1UOL152H7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministry of Health of the Slovak Republic
ID : 2018/11-UKMT-7
Organisme : Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and the Slovak Academy of Sciences
ID : VEGA 2/0044/20
Organisme : Competence Centre Martin
ID : ITMS code: 26220220153
Organisme : Slovak Research and Development Agency
ID : APVV-19-0324
Organisme : MVTS SKTW AMAZON
ID : SAS-MOST JRP 2021/2
Organisme : Structural Funds of EU, Ministry of Education, Slovakia
ID : ITMS 313011T548 MODEX

Références

Cold Spring Harb Perspect Biol. 2017 Jul 5;9(7):
pubmed: 28062563
J Magn Reson Imaging. 1994 May-Jun;4(3):497-505
pubmed: 7802866
Int J Mol Sci. 2020 Aug 31;21(17):
pubmed: 32878313
Int J Mol Sci. 2021 Apr 20;22(8):
pubmed: 33923880
Protein Sci. 1993 Mar;2(3):404-10
pubmed: 8453378
Metallomics. 2014 Apr;6(4):748-73
pubmed: 24549403
Br J Haematol. 2018 May;181(3):331-340
pubmed: 29672840
Front Neurosci. 2019 Mar 01;13:180
pubmed: 30881284
Biochim Biophys Acta. 2010 Aug;1800(8):719-31
pubmed: 20382203
Int J Mol Sci. 2021 Aug 06;22(16):
pubmed: 34445190
Biochim Biophys Acta. 2010 Aug;1800(8):770-82
pubmed: 20447447
Neurobiol Dis. 2018 May;113:1-10
pubmed: 29414379
Sci Rep. 2017 Jan 23;7:41051
pubmed: 28112214
Parkinsonism Relat Disord. 2011 Jul;17(6):423-30
pubmed: 21550835
NPJ Vaccines. 2021 Dec 13;6(1):151
pubmed: 34903722
J Mol Biol. 2000 Jul 14;300(3):541-9
pubmed: 10884350
J Struct Biol. 2004 Aug;147(2):166-78
pubmed: 15193645
Biochim Biophys Acta Gen Subj. 2018 Aug;1862(8):1760-1769
pubmed: 29751097
J Biol Phys. 2018 Sep;44(3):237-243
pubmed: 29740739
Langmuir. 2018 Aug 21;34(33):9789-9797
pubmed: 30060667
J Struct Biol. 1999 Jun 30;126(3):182-94
pubmed: 10441528
Blood Rev. 2009 May;23(3):95-104
pubmed: 18835072
Expert Rev Neurother. 2012 Dec;12(12):1467-80
pubmed: 23237353
Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12
pubmed: 17245412
Brain Res Bull. 2017 Jul;133:71-79
pubmed: 27545490
J Mol Biol. 1963 May;6:404-22
pubmed: 13953005
Talanta. 2017 Nov 1;174:819-837
pubmed: 28738659
J Phys Condens Matter. 2017 Oct 18;29(41):415801
pubmed: 28872048
Front Chem Sci Eng. 2017 Dec;11(4):633-646
pubmed: 29503759
Nanotechnology. 2010 Feb 10;21(6):065103
pubmed: 20061598
Sci Rep. 2020 Jun 25;10(1):10332
pubmed: 32587293
Cell Biochem Biophys. 2019 Mar;77(1):15-32
pubmed: 29704106
Prion. 2020 Dec;14(1):67-75
pubmed: 32008441

Auteurs

Jan Gombos (J)

Department of Medical Biochemistry, Jessenius Faculty of Medicine, Comenius University, 036 01 Martin, Slovakia.

Lucia Balejcikova (L)

Institute of Hydrology, Slovak Academy of Sciences, 841 01 Bratislava, Slovakia.

Peter Kopcansky (P)

Institute of Experimental Physics, Slovak Academy of Sciences, 040 01 Kosice, Slovakia.

Marianna Batkova (M)

Institute of Experimental Physics, Slovak Academy of Sciences, 040 01 Kosice, Slovakia.

Katarina Siposova (K)

Institute of Experimental Physics, Slovak Academy of Sciences, 040 01 Kosice, Slovakia.

Jozef Kovac (J)

Institute of Experimental Physics, Slovak Academy of Sciences, 040 01 Kosice, Slovakia.

Kristina Zolochevska (K)

Institute of Experimental Physics, Slovak Academy of Sciences, 040 01 Kosice, Slovakia.

Ivo Safarik (I)

Department of Nanobiotechnology, Biology Centre, ISBB, Czech Academy of Sciences, 370 05 Ceske Budejovice, Czech Republic.
Regional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute, Palacky University, 779 00 Olomouc, Czech Republic.

Alica Lokajova (A)

Department of Medical Biochemistry, Jessenius Faculty of Medicine, Comenius University, 036 01 Martin, Slovakia.

Vasil M Garamus (VM)

Helmholtz-Zentrum Hereon, Max-Planck-Str. 1, 21502 Geesthacht, Germany.

Dusan Dobrota (D)

Department of Medical Biochemistry, Jessenius Faculty of Medicine, Comenius University, 036 01 Martin, Slovakia.

Oliver Strbak (O)

Biomedical Center Martin, Jessenius Faculty of Medicine, Comenius University, 036 01 Martin, Slovakia.

Articles similaires

alpha-Synuclein Humans Animals Mice Lewy Body Disease

Amyloid accelerator polyphosphate fits as the mystery density in α-synuclein fibrils.

Philipp Huettemann, Pavithra Mahadevan, Justine Lempart et al.
1.00
Polyphosphates alpha-Synuclein Humans Amyloid Molecular Dynamics Simulation
Soil Pollutants Cadmium Arsenic Soil Microbiology Iron

Classifications MeSH